Copyright Reports & Markets. All rights reserved.

Global Regenerative Medicine Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Regenerative Medicine Market Overview

    • 1.1 Product Overview and Scope of Regenerative Medicine
    • 1.2 Classification of Regenerative Medicine by Types
      • 1.2.1 Global Regenerative Medicine Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Regenerative Medicine Revenue Market Share by Types in 2018
      • 1.2.3 Cell Therapy
      • 1.2.4 Tissue Engineering
      • 1.2.5 Biomaterial
      • 1.2.6 Others
    • 1.3 Global Regenerative Medicine Market by Application
      • 1.3.1 Global Regenerative Medicine Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Dermatology
      • 1.3.3 Cardiovascular
      • 1.3.4 CNS
      • 1.3.5 Orthopedic
      • 1.3.6 Others
    • 1.4 Global Regenerative Medicine Market by Regions
      • 1.4.1 Global Regenerative Medicine Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Regenerative Medicine Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Regenerative Medicine Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Regenerative Medicine Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Regenerative Medicine Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Regenerative Medicine Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Regenerative Medicine (2014-2024)

    2 Manufacturers Profiles

    • 2.1 J & J (DePuy Synthes)
      • 2.1.1 Business Overview
      • 2.1.2 Regenerative Medicine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 J & J (DePuy Synthes) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Medtronic
      • 2.2.1 Business Overview
      • 2.2.2 Regenerative Medicine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 ZimmerBiomet
      • 2.3.1 Business Overview
      • 2.3.2 Regenerative Medicine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 ZimmerBiomet Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Stryker
      • 2.4.1 Business Overview
      • 2.4.2 Regenerative Medicine Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Allergan(Acelity)
      • 2.5.1 Business Overview
      • 2.5.2 Regenerative Medicine Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Allergan(Acelity) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 MiMedx Group
      • 2.6.1 Business Overview
      • 2.6.2 Regenerative Medicine Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Organogenesis
      • 2.7.1 Business Overview
      • 2.7.2 Regenerative Medicine Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Fujifilm Cellular Dynamics
      • 2.8.1 Business Overview
      • 2.8.2 Regenerative Medicine Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Osiris Therapeutics
      • 2.9.1 Business Overview
      • 2.9.2 Regenerative Medicine Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Vcanbio
      • 2.10.1 Business Overview
      • 2.10.2 Regenerative Medicine Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 CCBC
      • 2.11.1 Business Overview
      • 2.11.2 Regenerative Medicine Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 CCBC Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Cytori
      • 2.12.1 Business Overview
      • 2.12.2 Regenerative Medicine Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Cytori Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Celgene
      • 2.13.1 Business Overview
      • 2.13.2 Regenerative Medicine Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Celgene Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Vericel Corporation
      • 2.14.1 Business Overview
      • 2.14.2 Regenerative Medicine Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Vericel Corporation Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Guanhao Biotech
      • 2.15.1 Business Overview
      • 2.15.2 Regenerative Medicine Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Guanhao Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Mesoblast
      • 2.16.1 Business Overview
      • 2.16.2 Regenerative Medicine Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Mesoblast Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 AMAG Pharmaceuticals (CBR)
      • 2.17.1 Business Overview
      • 2.17.2 Regenerative Medicine Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 ViaCord
      • 2.18.1 Business Overview
      • 2.18.2 Regenerative Medicine Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 ViaCord Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 CordLife
      • 2.19.1 Business Overview
      • 2.19.2 Regenerative Medicine Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 CordLife Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 Integra LifeSciences
      • 2.20.1 Business Overview
      • 2.20.2 Regenerative Medicine Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 Integra LifeSciences Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 Nuvasive
      • 2.21.1 Business Overview
      • 2.2.2 Regenerative Medicine Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 Nuvasive Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.22 Cook Biotech
      • 2.22.1 Business Overview
      • 2.22.2 Regenerative Medicine Type and Applications
        • 2.22.2.1 Product A
        • 2.22.2.2 Product B
      • 2.22.3 Cook Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.23 Japan Tissue Engineering
      • 2.23.1 Business Overview
      • 2.23.2 Regenerative Medicine Type and Applications
        • 2.23.2.1 Product A
        • 2.23.2.2 Product B
      • 2.23.3 Japan Tissue Engineering Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Regenerative Medicine Market Competition, by Players

    • 3.1 Global Regenerative Medicine Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Regenerative Medicine Players Market Share
      • 3.2.2 Top 10 Regenerative Medicine Players Market Share
    • 3.3 Market Competition Trend

    4 Global Regenerative Medicine Market Size by Regions

    • 4.1 Global Regenerative Medicine Revenue and Market Share by Regions
    • 4.2 North America Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 4.5 South America Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Regenerative Medicine Revenue and Growth Rate (2014-2019)

    5 North America Regenerative Medicine Revenue by Countries

    • 5.1 North America Regenerative Medicine Revenue by Countries (2014-2019)
    • 5.2 USA Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Regenerative Medicine Revenue and Growth Rate (2014-2019)

    6 Europe Regenerative Medicine Revenue by Countries

    • 6.1 Europe Regenerative Medicine Revenue by Countries (2014-2019)
    • 6.2 Germany Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 6.3 UK Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 6.4 France Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Regenerative Medicine Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Regenerative Medicine Revenue by Countries

    • 7.1 Asia-Pacific Regenerative Medicine Revenue by Countries (2014-2019)
    • 7.2 China Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 7.5 India Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Regenerative Medicine Revenue and Growth Rate (2014-2019)

    8 South America Regenerative Medicine Revenue by Countries

    • 8.1 South America Regenerative Medicine Revenue by Countries (2014-2019)
    • 8.2 Brazil Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Regenerative Medicine Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Regenerative Medicine by Countries

    • 9.1 Middle East and Africa Regenerative Medicine Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Regenerative Medicine Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Regenerative Medicine Revenue and Growth Rate (2014-2019)

    10 Global Regenerative Medicine Market Segment by Type

    • 10.1 Global Regenerative Medicine Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Regenerative Medicine Market Forecast by Type (2019-2024)
    • 10.3 Cell Therapy Revenue Growth Rate (2014-2024)
    • 10.4 Tissue Engineering Revenue Growth Rate (2014-2024)
    • 10.5 Biomaterial Revenue Growth Rate (2014-2024)
    • 10.6 Others Revenue Growth Rate (2014-2024)

    11 Global Regenerative Medicine Market Segment by Application

    • 11.1 Global Regenerative Medicine Revenue Market Share by Application (2014-2019)
    • 11.2 Regenerative Medicine Market Forecast by Application (2019-2024)
    • 11.3 Dermatology Revenue Growth (2014-2019)
    • 11.4 Cardiovascular Revenue Growth (2014-2019)
    • 11.5 CNS Revenue Growth (2014-2019)
    • 11.6 Orthopedic Revenue Growth (2014-2019)
    • 11.7 Others Revenue Growth (2014-2019)

    12 Global Regenerative Medicine Market Size Forecast (2019-2024)

    • 12.1 Global Regenerative Medicine Market Size Forecast (2019-2024)
    • 12.2 Global Regenerative Medicine Market Forecast by Regions (2019-2024)
    • 12.3 North America Regenerative Medicine Revenue Market Forecast (2019-2024)
    • 12.4 Europe Regenerative Medicine Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Regenerative Medicine Revenue Market Forecast (2019-2024)
    • 12.6 South America Regenerative Medicine Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Regenerative Medicine Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

      Scope of the Report:
      The classification of Regenerative Medicine includes Cell Therapy and Tissue Engineering, Biomaterial and Others, and the proportion of Tissue Engineering is about 41% in 2017, and the proportion is in increasing trend from 2013 to 2017.
      The global Regenerative Medicine market is valued at 19800 million USD in 2018 and is expected to reach 47800 million USD by the end of 2024, growing at a CAGR of 19.3% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Regenerative Medicine.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Regenerative Medicine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Regenerative Medicine market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      J & J (DePuy Synthes)
      Medtronic
      ZimmerBiomet
      Stryker
      Allergan(Acelity)
      MiMedx Group
      Organogenesis
      Fujifilm Cellular Dynamics
      Osiris Therapeutics
      Vcanbio
      CCBC
      Cytori
      Celgene
      Vericel Corporation
      Guanhao Biotech
      Mesoblast
      AMAG Pharmaceuticals (CBR)
      ViaCord
      CordLife
      Integra LifeSciences
      Nuvasive
      Cook Biotech
      Japan Tissue Engineering

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Cell Therapy
      Tissue Engineering
      Biomaterial
      Others

      Market Segment by Applications, can be divided into
      Dermatology
      Cardiovascular
      CNS
      Orthopedic
      Others

      Buy now